210 related articles for article (PubMed ID: 33675063)
1. Circulating anti-citrullinated protein antibodies containing secretory component are prognostic for arthritis onset in at-risk patients.
Roos Ljungberg K; Martinsson K; Wetterö J; Svärd A; Kastbom A
Clin Exp Immunol; 2021 Jun; 204(3):344-351. PubMed ID: 33675063
[TBL] [Abstract][Full Text] [Related]
2. Elevated free secretory component in early rheumatoid arthritis and prior to arthritis development in patients at increased risk.
Martinsson K; Roos Ljungberg K; Ziegelasch M; Cedergren J; Eriksson P; Klimovich V; Reckner Å; Griazeva I; Sjöwall C; Samoylovich M; Skogh T; Wetterö J; Kastbom A
Rheumatology (Oxford); 2020 May; 59(5):979-987. PubMed ID: 31504979
[TBL] [Abstract][Full Text] [Related]
3. Determination of Autoantibody Isotypes Increases the Sensitivity of Serodiagnostics in Rheumatoid Arthritis.
Sieghart D; Platzer A; Studenic P; Alasti F; Grundhuber M; Swiniarski S; Horn T; Haslacher H; Blüml S; Smolen J; Steiner G
Front Immunol; 2018; 9():876. PubMed ID: 29740454
[TBL] [Abstract][Full Text] [Related]
4. Changes in anti-citrullinated protein antibody isotype levels in relation to disease activity and response to treatment in early rheumatoid arthritis.
Kastbom A; Roos Ljungberg K; Ziegelasch M; Wetterö J; Skogh T; Martinsson K
Clin Exp Immunol; 2018 Dec; 194(3):391-399. PubMed ID: 30136282
[TBL] [Abstract][Full Text] [Related]
5. Extramucosal Formation and Prognostic Value of Secretory Antibodies in Rheumatoid Arthritis.
Martinsson K; Kling LL; Roos-Ljungberg K; Griazeva I; Samoylovich M; Paul S; Rönnelid J; Weitoft T; Wetterö J; Kastbom A
Arthritis Rheumatol; 2022 May; 74(5):801-809. PubMed ID: 34927393
[TBL] [Abstract][Full Text] [Related]
6. Secretory anti-citrullinated protein antibodies in serum associate with lung involvement in early rheumatoid arthritis.
Roos Ljungberg K; Joshua V; Skogh T; Eklund A; Sköld CM; Karimi R; Nyrén S; Svärd A; Catrina AI; Kastbom A
Rheumatology (Oxford); 2020 Apr; 59(4):852-859. PubMed ID: 31504962
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic utility of, and influence of tobacco usage and genetic predisposition on, immunoglobulin A, rheumatoid factor and anti-citrullinated peptide auto-antibodies in South African rheumatoid arthritis patients.
Meyer P; Ally M; Hodkinson B; Anderson R; Tikly M
Afr Health Sci; 2018 Jun; 18(2):295-303. PubMed ID: 30602956
[TBL] [Abstract][Full Text] [Related]
8. The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patients.
van Delft MAM; Verheul MK; Burgers LE; Derksen VFAM; van der Helm-van Mil AHM; van der Woude D; Huizinga TWJ; Toes REM; Trouw LA
Arthritis Res Ther; 2017 Aug; 19(1):190. PubMed ID: 28810902
[TBL] [Abstract][Full Text] [Related]
9. Anti-Citrullinated Protein Antibody Specificities, Rheumatoid Factor Isotypes, and Incident Cardiovascular Events in Patients With Rheumatoid Arthritis.
Westerlind H; Rönnelid J; Hansson M; Alfredsson L; Mathsson-Alm L; Serre G; Cornillet M; Holmdahl R; Jakobsson PJ; Skriner K; Klareskog L; Saevarsdottir S; Askling J
Arthritis Rheumatol; 2020 Oct; 72(10):1658-1667. PubMed ID: 32475073
[TBL] [Abstract][Full Text] [Related]
10. Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis.
Oka S; Higuchi T; Furukawa H; Shimada K; Okamoto A; Hashimoto A; Komiya A; Saisho K; Yoshikawa N; Katayama M; Matsui T; Fukui N; Migita K; Tohma S
BMC Musculoskelet Disord; 2022 Jan; 23(1):46. PubMed ID: 35027028
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies are major predictors of arthritis development in patients with anti-citrullinated protein antibodies and musculoskeletal pain.
Eloff E; Martinsson K; Ziegelasch M; Cedergren J; Reckner Å; Skogh T; Karlsson L; Ärlemalm A; Borggreven NV; Trouw LA; Kastbom A
Scand J Rheumatol; 2021 May; 50(3):189-197. PubMed ID: 33243072
[No Abstract] [Full Text] [Related]
12. Presence of salivary IgA anti-citrullinated protein antibodies associate with higher disease activity in patients with rheumatoid arthritis.
Roos Ljungberg K; Börjesson E; Martinsson K; Wetterö J; Kastbom A; Svärd A
Arthritis Res Ther; 2020 Nov; 22(1):274. PubMed ID: 33225988
[TBL] [Abstract][Full Text] [Related]
13. Differing specificities and isotypes of anti-citrullinated peptide/protein antibodies in palindromic rheumatism and rheumatoid arthritis.
Cabrera-Villalba S; Gomara MJ; Cañete JD; Ramírez J; Salvador G; Ruiz-Esquide V; Hernández MV; Inciarte-Mundo J; Haro I; Sanmartí R
Arthritis Res Ther; 2017 Jun; 19(1):141. PubMed ID: 28619044
[TBL] [Abstract][Full Text] [Related]
14. Baseline serum levels of IgA anti-cyclic citrullinated protein antibodies in early rheumatoid arthritis predict radiographic progression after 11 years of treatment: a secondary analysis of the CIMESTRA study.
Rasmussen EB; Thiele LS; Stengaard-Pedersen K; Hetland ML; Hørslev-Petersen K; Junker P; Østergaard M; Hansen AS; Hvid M; Deleuran B; Greisen SR
Scand J Rheumatol; 2023 Sep; 52(5):493-497. PubMed ID: 36255383
[TBL] [Abstract][Full Text] [Related]
15. Antibodies against citrullinated peptides are associated with clinical and radiological outcomes in patients with early rheumatoid arthritis: a prospective longitudinal inception cohort study.
Boman A; Brink M; Lundquist A; Hansson M; Mathsson-Alm L; Rönnelid J; Berglin E; Holmdahl R; Skriner K; Serre G; Klareskog L; Rantapää-Dahlqvist S
RMD Open; 2019; 5(2):e000946. PubMed ID: 31565241
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of serum protein electrophoresis constituents for arthritis development in anti-citrullinated protein antibody-positive patients with musculoskeletal pain.
Åhammar S; Martinsson K; Ziegelasch M; Kastbom A
Scand J Rheumatol; 2024 Mar; 53(2):118-122. PubMed ID: 38214468
[TBL] [Abstract][Full Text] [Related]
17. Does information on novel identified autoantibodies contribute to predicting the progression from undifferentiated arthritis to rheumatoid arthritis: a study on anti-CarP antibodies as an example.
Boeters DM; Trouw LA; van der Helm-van Mil AHM; van Steenbergen HW
Arthritis Res Ther; 2018 May; 20(1):94. PubMed ID: 29724250
[TBL] [Abstract][Full Text] [Related]
18. Secretory antibodies to citrullinated peptides in plasma and saliva from rheumatoid arthritis patients and their unaffected first-degree relatives.
Svärd A; Roos Ljungberg K; Brink M; Martinsson K; Sjöwall C; Rantapää Dahlqvist S; Kastbom A
Clin Exp Immunol; 2020 Feb; 199(2):143-149. PubMed ID: 31605388
[TBL] [Abstract][Full Text] [Related]
19. Arthritis autoantibodies in individuals without rheumatoid arthritis: follow-up data from a Dutch population-based cohort (Lifelines).
Westra J; Brouwer E; Raveling-Eelsing E; Arends S; Eman Abdulle A; Roozendaal C; van Delft MAM; Toes REM; Trouw LA; Vissink A; de Smit MJ
Rheumatology (Oxford); 2021 Feb; 60(2):658-666. PubMed ID: 32594174
[TBL] [Abstract][Full Text] [Related]
20. N-Linked Glycans in the Variable Domain of IgG Anti-Citrullinated Protein Antibodies Predict the Development of Rheumatoid Arthritis.
Hafkenscheid L; de Moel E; Smolik I; Tanner S; Meng X; Jansen BC; Bondt A; Wuhrer M; Huizinga TWJ; Toes REM; El-Gabalawy H; Scherer HU
Arthritis Rheumatol; 2019 Oct; 71(10):1626-1633. PubMed ID: 31067000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
